“A priori” | “A posteriori” | |||
---|---|---|---|---|
Predictive | Descriptive | |||
Model 1 | Model 2 | Model 3 | Model 4 | |
Dependent variables | Persistent asthma symptoms at follow-up | Persistent NSBHR at follow-up | Persistent asthma symptoms at follow-up | Persistent asthma symptoms at follow-up |
Co-variates | ||||
Age at T0 | 0.08 (p = 0.02) | 0.03 (p = 0.35) | 0.04 (p = 0.27) | |
Age at T1 | 0.09 (p = 0.06) | |||
Total exposure time | -0.02 (p = 0.04) | |||
Symptomatic exposure time | 0.01 (p = 0.37) | 0.03 (p = 0.10) | ||
Upper airway symptoms at T0 | -1.91 (p = 0.12) | |||
Upper airway symptoms at T1 | 1.36 (p = 0.29) | |||
FEV1/FVC at T0 | -0.11 (p = 0.05) | |||
Asthma medication at T1 | 2.85 (p < 0.001) | |||
Intercept | -2.90 | -0.32 | 9.01 | -5.98 |
R2 | 0.22 | 0.28 | 0.39 | 0.55 |